Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Masahiko Kouroki"'
Autor:
Toru Fujisaki, Tetsuji Sato, Jiro Inagaki, Toshiya Matsuishi, Masahiko Kouroki, Junji Kamizono, Masahiro Yasui
Publikováno v:
Pediatric Blood & Cancer. 68
Autor:
Masahiko Kouroki, Takafumi Ohmura, Hirofumi Jono, Fumio Endo, Kazuaki Taguchi, Hideyuki Saito
Publikováno v:
Pediatrics International. 56:e33-e36
Imatinib mesylate, a selective tyrosine kinase inhibitor, is the frontline therapeutic agent used for the treatment of chronic myeloid leukemia (CML), and its therapeutic efficacy is associated with trough concentrations. Therefore, monitoring imatin
Publikováno v:
Pediatric Surgery International. 28:59-62
A girl presented with a right adrenal mass, and multiple hepatic lesions and subcutaneous nodules 3 months after complete resection of left adrenal neuroblastoma in the neonatal period. She was treated with six cycles of chemotherapy and is well afte
Autor:
Rieko Sakamoto, Hidekazu Yamamoto, Koushi Uchida, Shintaro Hayashida, Yukihiro Inomata, Tadashi Anan, Keita Shimata, Yasuhiko Sugawara, Tomonari Urabe, Masaki Honda, Masahiko Kouroki
Publikováno v:
Pediatric Transplantation. 21:e13039
Acute GVHD is a rare complication after liver transplantation that has a high mortality rate. We experienced an infant case complicated with acute GVHD. An 8-month-old infant with biliary atresia underwent LDLT with a graft obtained from his mother.
Autor:
Kazuaki, Taguchi, Masahiko, Kouroki, Takafumi, Ohmura, Hirofumi, Jono, Fumio, Endo, Hideyuki, Saito
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 56(4)
Imatinib mesylate, a selective tyrosine kinase inhibitor, is the frontline therapeutic agent used for the treatment of chronic myeloid leukemia (CML), and its therapeutic efficacy is associated with trough concentrations. Therefore, monitoring imatin
Autor:
Akihisa, Sawada, Naoki, Sakata, Banryoku, Higuchi, Yasufumi, Takeshita, Takashi, Ishihara, Akifumi, Sakata, Masahiko, Kouroki, Osamu, Kondo, Maho, Koyama, Shinya, Hirano, Masahiro, Yasui, Masami, Inoue, Akira, Yoshioka, Keisei, Kawa
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 50(12)
Invasive fungal infection (IFI) is a serious complication of chemotherapy for hematological malignancies and autologous/allogeneic hematopoietic stem cell transplantation in children and shows a high mortality rate. We performed a randomized trial co
Autor:
Masami, Inoue, Masahiro, Yasui, Akihisa, Sawada, Maho, Koyama, Osamu, Kondo, Takako, Miyamura, Banryoku, Higuchi, Masahiko, Kouroki, Takashi, Ishihara, Keisei, Kawa
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 48(11)
The results of allogeneic stem cell transplantation for patients with chemotherapy-resistant non-remission acute leukemia have been very poor. We have used a melphalan-preceding intensified preparative regimen in which a six-day interval is set betwe
Autor:
Masami, Inoue, Masahiro, Yasui, Akihisa, Sawada, Maho, Koyama, Akifumi, Sakata, Yasufumi, Takeshita, Masahiko, Kouroki, Takayuki, Okamura, Naoki, Sakata, Keisei, Kawa
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 47(11)
We report the results of 39 children who underwent cord blood stem cell transplantation (CBSCT) at our institute during the period from February 1996 to July 2005. The patients consisted of 9 with non-malignant disease, 26 with malignant disease and
Autor:
Yasufumi Takeshita, Masami Inoue, Masahiro Yasui, Takayuki Okamura, Akihisa Sawada, K Yagi, Masahiko Kouroki, Naoki Sakata, Keisei Kawa, Maho Koyama, Akifumi Sakata
Publikováno v:
Bone marrow transplantation. 37(6)
Eight children underwent reduced-intensity stem cell transplantation (RIST) from an HLA-matched sibling. They received a fludarabine-melphalan based preparative regimen. Stem cell source was bone marrow, and GVHD prophylaxis consisted of cyclosporine